Not a Lexis Advance subscriber? Try it out for free.


Company Halts Ovarian Cancer Test Sales After FDA Warning

The U.K.-based maker of a test for ovarian cancer on Tuesday said that it had decided to suspend its sales in the U.S. after the U.S. Food and Drug Administration last week warned that there are currently no reliable ovarian cancer tests available. more